Lakefront Biotherapeutics NV (GLPG) Form 6-K — Sep 1, 2026
Lakefront Biotherapeutics NV repurchased 127,796 of its own shares between August 24 and August 28, 2026, spending €3,218,710.15 at an average price of €25.19 per share under the buyback program announced on June 9, 2026. The purchases were executed through a discretionary mandate with an independent financial intermediary across Euronext Amsterdam and other multilateral trading facilities, with per-share prices ranging from €24.36 to €25.66. As of the market close on August 28, 2026, the Belgian biotech holds 1,161,324 of its own ordinary shares in treasury.
Key figures
- Purchase Window
- 2026-08-24 to 2026-08-28
- Lowest Price Paid Eur
- 24.36
- Average Price Paid Eur
- 25.19
- Highest Price Paid Eur
- 25.66
- Shares Repurchased Week
- 127796
- Repurchase Program Announced
- 2026-06-09
- Treasury Shares Held As Of Aug28
- 1161324
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.